New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

Amplify Weight Loss Drug & Treatment ETF

This ETF provides exposure to Equities

THNR performance and flow charts

Last update 8/28/2026 at 1:30 PM
Live
Closed
Last price
$26.96
-$0.56 (-2.02%) 8/28/2026

Performance

-2.00.02.04.06.0%Jul 28Aug 4Aug 11Aug 18Aug 25

Flows

0
1 day price range
$26.91
$27.00
52 week price range
$22.81
$27.82
1W perf
-2.07%
YTD perf
+7.09%
YTD flows
+$2M
AuM
$5M
E/R
0.59%
TTM yield
1.53%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of August 28, 2026
1M3MYTD1Y3Y5Y
Perf.+3.66%+8.79%+7.09%+20.19%
Flows-+$769K+$2M+$663K--
Data as of August 28, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Amplify Weight Loss Drug & Treatment ETF is built to track the VettaFi Weight Loss Drug & Treatment Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderAmplify ETFs
N° of holdings0
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateMay 21, 2024
ESGNo
TrackinsightTrackinsight

More data and info about THNR on Trackinsight

Exposure

Data as of January 1, 1970
The THNR ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. We're working to retrieve all detailed holding information.
Advertisement

Trading data

Last sale
8/28/2026 at 1:30 PM
$26.96
Previous close
$27.52
Consolidated volume
08/27/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+19.89%+17.93%
Max drawdown
-5.44%-12.38%
Max drawdown duration
31d160dN/AN/A
Time to recover
5d106dN/AN/A

Replication quality

Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Frequently asked questions about THNR

What type of ETF is THNR?

THNR is a Passive ETF that provides exposure to Equity assets. It is managed by Amplify ETFs.

What index does THNR track?

THNR tracks the VettaFi Weight Loss Drug & Treatment Index - USD, aiming to replicate its performance through full replication.

What does THNR invest in?

This ETF provides exposure to Equities. It is part of the segment: Tomorrow's Treatments.

What is the expense ratio of THNR?

The total expense ratio (TER) of THNR is 0.59%, representing the annual fee charged by the fund manager.

When was THNR launched?

THNR was launched on May 21, 2024, marking its entry into the ETF market.

Who is the issuer of THNR?

THNR is issued by Amplify ETFs.

What is the AUM of THNR?

As of August 28, 2026, THNR manages $5.39 M, reflecting the total assets held in the fund.

How has THNR performed recently?

As of August 28, 2026, THNR delivered a return of 3.66% over the past month (1M performance), 8.79% over the past three months (3M), and 7.09% year-to-date (YTD).

Does THNR pay dividends?

As of August 28, 2026, THNR has a trailing 12-month distribution yield of 1.53%.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026
ETF Takeaway: Ocean Park Diversified Income ETF (DUKZ)

ETF Takeaway

ETF Takeaway: Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management discusses the state of fixed income markets and how their DUKZ ETF, through their rules-based process, tactically allocates to 11 sectors of fixed income through underlying ETFs.

NYSE logo
By NYSE · August 18, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 17, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape:

Tidal
By Tidal · August 17, 2026

Browse all educational columns

ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder